In the modern era, what is the role of beta-emitting bone-targeted radiopharmaceutical therapy?  

Are you offering patients beta-emitters (Samarium-153 lexidronam, strontium-89) to any patients?

Answer from: Radiation Oncologist at Academic Institution
Radiation Oncologist at National Cancer Institute
In general agreement with Dr. @William W. Wong&nbs...
Radiation Oncologist at University of Missouri at Columbia, Ellis Fischel Cancer Cener
It is also to note that Samarium 153 EDTMP is (Qua...
Radiation Oncologist at Comprehensive Cancer Centers of Nevada
I try to use Samarium 153 often in breast and lung...
Sign in or Register to read more